Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;10(3):726-729.
doi: 10.1007/s13346-020-00743-2.

The solid progress of nanomedicine

João Pedro Martins  1 , José das Neves  2 , María de la Fuente  3 , Christian Celia  4 , Helena Florindo  5 , Nazende Günday-Türeli  6 , Amirali Popat  7 , José Luis Santos  8 , Flávia Sousa  2 , Ruth Schmid  9 , Joy Wolfram  10 , Bruno Sarmento  2 , Hélder A Santos  11   12
Affiliations

The solid progress of nanomedicine

João Pedro Martins et al. Drug Deliv Transl Res. 2020 Jun.

Abstract

This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. Graphical abstract.

Keywords: Cancer therapy; Clinical translation; Nanomedicine; Nanotechnology; Reproducibility.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

None
Graphical abstract
See this image and copyright information in PMC

References

    1. R.F. Service, U.S. cancer institute cancels nanotech research centers. Available at URL: https://www.sciencemag.org/news/2019/05/us-cancer-institute-cancels-nano.... Accessed 20 Jun 2019.
    1. Park K. The beginning of the end of the nanomedicine hype. J Control Release. 2019. - PubMed
    1. Grodzinski P. NCI Centers of Cancer Nanotechnology Excellence (CCNEs) - a full story to set the record straight. J Control Release. 2019. - PubMed
    1. Bhattacharyya J, Bellucci JJ, Weitzhandler I, McDaniel JR, Spasojevic I, Li X, Lin CC, Chi JT, Chilkoti A. A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models. Nat Commun. 2015;6:7939. - PMC - PubMed
    1. Laginha KM, Verwoert S, Charrois GJ, Allen TM. Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin Cancer Res. 2005;11(19 Pt 1):6944–6949. - PubMed

Publication types